- Monday, May 18, 2026
- India +91 7982732466
- U.S +1 217 953 4020
- Info@Shingetsuresearch.com
Global single cell multi omics Market by Product (Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics, Single Cell Metabolomics), By Application (Oncology, Cell Biology, Neurology, Immunology, Others), and By Region (North America, Europe, Asia Pacific, South America, and Middle East, & Africa)- Global forecast from 2022-2030.
Global single cell multi omics Market Overview
The global single-cell multi-omics market is estimated to reach USD 15.35 billion by 2030, growing at a CAGR of 20.12% during the forecast period of 2022-2030. It was valued at USD 2.31 billion in 2022. Single-cell analysis is to change the understanding of the disease. There is a growing realization that cell populations are more diverse and complex than human thinking. Advances in single-cell genomics, transcriptomics, and proteomics are also transforming clinical research, diagnosis, and treatment of various diseases. The single-cell multi-omics technology refers to multiple types of molecules from the individual cells, which is studied to understand the more biological insight than deducing from analyzing each molecular layer from separate cells.Global single cell multi omics Market Insights
Due to the rising adoption of personalized medicine, the use of non-invasive instruments, changing individual lifestyles, advancement in single-cell technology have fueled the market demand for the global single-cell multi-omics market. Single-cell sequencing refers to the technology of obtaining corresponding data and performing information analysis by sequencing a single cell at the genome, transcriptome, and epigenome levels. Single-cell sequencing can solve the problem of cell heterogeneity that cannot be solved by sequencing tissue samples, and provides a new method for analyzing the behavior, mechanism, and relationship between the single-cell and the body. The advantage of this type of method is that it can obtain higher coverage and accuracy information from a single cell, which is suitable for a high-quality analysis of precious samples that are difficult to obtain. Moreover, the rising number of chronic diseases has increased the market demand for single-cell multi-omics technology, which helps in finding the cure for diseases like cancer. Also, the rising personalized medicine market due to growing infections, have fueled the global market for a single cell multi-omics market. Additionally, growing biotechnology and the pharmaceutical industry have propelled the demand for non-invasive instruments, full applications for single-cell multi-omics technology, and conventional labs are bolstering the future clinical market.Growth Driver
Rising chronic diseases
The rising chronic diseases like cancer and infectious diseases caused due to viruses have emerged the market growth for the global single-cell multi-omics market. The advantage of single-cell technology is that additional layers of data associated with omics will add information that is critical to obtaining a full understanding of the biology of cellular heterogeneity.High-tech technology
Based on high-tech technology, scientists have started using tools that allow the use of single-cell sequencing for the exploration of cellular heterogeneity. It helps in improving personalized medicines and a rise in the development of the pharmaceutical industry and the health of the patient.By Product Segmental Analysis
Based on the product, the global single-cell multi-omics market segmented into Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics, Single Cell Metabolomics. Single-cell transcriptomics has captured the largest segment in the global single-cell multi-omics market. Transcriptome broadly refers to the collection of all transcription products in a cell under a particular physiological condition, including messenger RNA, ribosomal RNA, transport RNA, and non-coding RNA; narrowly refers to the collection of all mRNAs. Transcriptome sequencing can detect the overall transcription activity of any species without designing probes for known sequences in advance. It provides accurate digital signals, higher detection throughput, and a more comprehensive range detection used for an in-depth study of the complexity of the transcriptome.By Application Segmental Analysis
Based on the Application, the global single-cell multi-omics market classified into Oncology, Cell Biology, Neurology, Immunology, Others. Oncology holds the largest market share in the global single-cell multi-omics market. Tumors and immunity are the most complex physiological environment in the body. Increasing evidence shows that tumorigenesis and development are strictly related to the dysfunction of the immune system. In the tumor environment, no matter tumor cells or immune cells, there are a large number of specific mutation sites or surface markers. Extensive heterogeneity of cells in the body, the timeliness of the expression of related factors, and the dynamic process of changes all seriously affect the effectiveness of the treatment plan. Therefore, oncology has fueled the market demand for the global single-cell multi-omics market in the forecast period from 2022-2030.By Region Segmental Analysis
Based on geography, the global single-cell multi-omics market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. The Asia Pacific will be expecting to witness the highest growth during the forecast period from 2022-2030. The number of cancer cases is increasing, growing patients, outsourcing of the drug discovery is rising, and investment in R&D for diagnostic labs, technology advancement is propelling the market demand. Moreover, North America is currently leading the market of the single-cell multi-omics market.Competitor Analysis
Companies such as 10x Genomics, Inc., MissionBio, 1CellBio, NanoString Technologies, Inc., Fluxion Biosciences, Fluidigm Corporation, Celsee, Inc., Bio-Rad Laboratories, Inc., BGI Genomics Co. Ltd., GE LifeSciences, Illumina, Inc., and Takara Bio, QIAGEN N.V., among others, are key players in the global single-cell multi-omics market.Key Stakeholders
- Market research and consulting firms
- Industry associations
- Global single cell multi omics manufacturing companies
- Research organizations and consulting companies’ single cell multi omics
- Regulatory bodies
Scope of the report
| Report Attribute | Details |
|---|---|
| Market size value in 2020 | USD 2.31 Billion |
| Revenue forecast in 2027 | USD 5.35 Billion |
| Growth Rate | CAGR of 16.12% from 2020 to 2027 |
| Historical data | 2017-2019 |
| Forecast period | 2021 – 2027 |
| Region covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
| Key companies Profiled | 10x Genomics, Inc., Fluxion Biosciences, MissionBio, 1CellBio, NanoString Technologies, Inc., Fluidigm Corporation, Celsee, Inc., Bio-Rad Laboratories, Inc., BGI Genomics Co. Ltd., GE LifeSciences, Illumina, Inc., and Takara Bio, QIAGEN N.V. |
Recent Developments
- In September 2021, IsoPlexis introduced integrated Single-Cell Functional Multi-omic Biology Platform Duomic to simultaneously measure gene expression and functional protein levels from the same cell.
- In September 2021, Deepcell Collaborated with Stanford University on Chan Zuckerberg Biohub’s cell atlas project.
- In September 2021, Tapestri Platform enabled a broader range of Single Cell Studies in Heme-Oncology Research.
The objective of the Research
- Market modeling starts with identifying a target market where historical data exists. A Market can include prediction problems, economic factors, analyzing customer behavior, and identifying new patterns from past events, which helps our client to have deep dive into the market.
- Product analysis involves steps such as examining product features, costs, availability, quality, and other aspects. Product analysis is conducted to understand potential buyers and measure competition in the market.
- Market Trend and Economic Factors Analysis helps in assessing potential changes to an economy’s inflation rate, taxes, interest rates, exchange rates, trading regulations, and excise duties that can or have a major effect on the target market.
- Market Segmental Analysis defines in-depth scenario of the target market by the process of grouping consumers into naturally existing created segments of consumers who share similar product preferences or characteristics
- The geographical mapping approach helps our clients to understand national or international markets because different consumers in different regions have different needs wants, and cultural characteristics that can be specifically targeted.
Market Modelling
By Product- Consumables
- Service
- Biomarkers
- Safety
- Efficacy
- Validation
- Digital biomarkers
- Longitudinal
- Continuous Measurement
- Cancer
- Cardiovascular Disorders
- Diagnostics Development
- Drug Discovery and Development
- Disease-Risk
- Europe
- North America
- Asia Pacific
- South America
- Middle East & Africa
More Related Reports:
Drone Logistics and Transportation Market
Global Synthetic Rubber Market
Automated Optical Inspection Market
Enteric Disease Testing Market
Asia-Pacific Liquid Chromatography Market
Report Content
- Research Strategic Development
1.1. Market Modelling
1.2. Product Analysis
1.3. Market Trend and Economic Factors Analysis
1.4. Market Segmental Analysis
1.5. Geographical Mapping
1.6. Country Wise Segregation
- Research Methodology
2.1. Identification of Target Market
2.2. Data Acquisition
2.3. Refining of Data/ Data Transformations
2.4. Data Validation through Primary Techniques
2.5. Exploratory Data Analysis
2.6. Graphical Techniques/Analysis
2.7. Quantitative Techniques/Analysis
2.8. Visual Result/Presentation
- Executive Summary
- Market Insights
4.1. Supply Chain Analysis
4.2. Economic Factor Analysis
4.2.1. Drivers
4.2.2. Trends
4.2.3. Opportunities
4.2.4. Challenges
4.3. Technological Landscape
4.4. Competitors & Product Analysis
4.5. Regulatory Framework
4.6. Company market share analysis, 2022
4.7. Porter’s Five forces analysis
4.8. Price point analysis
4.9. New Investment Analysis
4.10. PESTEL Analysis
- Global Single Cell Multi Omics Market Overview
5.1. Market Size & Forecast,2017-2030
5.1.1. Demand
5.1.1.1. By Value (USD Billion)
5.2. Market Share & Forecast, 2017-2030
5.2.1. By Product Type
5.2.1.1. Single Cell Genomics
5.2.1.2. Single Cell Proteomics
5.2.1.3. Single Cell Transcriptomics
5.2.1.4. Single Cell Metabolomics
5.2.2. By Application
5.2.2.1. Oncology
5.2.2.2. Cell Biology
5.2.2.3. Neurology
5.2.2.4. Immunology
5.2.2.5. Others
5.2.3. By Region
5.2.3.1. North America
5.2.3.2. Europe
5.2.3.3. Asia-Pacific
5.2.3.4. South America
5.2.3.5. The Middle East & Africa
- North America Single Cell Multi Omics Market Overview
6.1. North America Single Cell Multi Omics Market Size & Forecast,2017-2030
6.1.1. Demand
6.1.1.1. By Value (USD Billion)
6.2. Market Share & Forecast, 2017-2030
6.2.1. By Product Type
6.2.1.1. Single Cell Genomics
6.2.1.2. Single Cell Proteomics
6.2.1.3. Single Cell Transcriptomics
6.2.1.4. Single Cell Metabolomics
6.2.2. By Application
6.2.2.1. Oncology
6.2.2.2. Cell Biology
6.2.2.3. Neurology
6.2.2.4. Immunology
6.2.2.5. Others
6.2.3. By Country
6.2.3.1. US
6.2.3.2. Canada
6.2.3.3. Mexico
6.2.4. Company Market Share (Top 3-5)
6.2.5. Economic Impact Study on North America Single Cell Multi Omics Market
- Europe Single Cell Multi Omics Market Overview
7.1. Europe Single Cell Multi Omics Market Size & Forecast,2017-2030
7.1.1. Demand
7.1.1.1. By Value (USD Billion)
7.2. Market Share & Forecast, 2017-2030
7.2.1. By Product Type
7.2.1.1. Single Cell Genomics
7.2.1.2. Single Cell Proteomics
7.2.1.3. Single Cell Transcriptomics
7.2.1.4. Single Cell Metabolomics
7.2.2. By Application
7.2.2.1. Oncology
7.2.2.2. Cell Biology
7.2.2.3. Neurology
7.2.2.4. Immunology
7.2.2.5. Others
7.2.3. By Country
7.2.3.1. Germany
7.2.3.2. UK
7.2.3.3. France
7.2.3.4. Italy
7.2.3.5. Rest of Europe
7.2.4. Company Market Share (Top 3-5)
7.2.5. Economic Impact Study on Europe Single Cell Multi Omics Market
- Asia-Pacific Single Cell Multi Omics Market Overview
8.1. Asia-Pacific Single Cell Multi Omics Market Size & Forecast,2017-2030
8.1.1. Demand
8.1.1.1. By Value (USD Billion)
8.2. Market Share & Forecast, 2017-2030
8.2.1. By Product Type
8.2.1.1. Single Cell Genomics
8.2.1.2. Single Cell Proteomics
8.2.1.3. Single Cell Transcriptomics
8.2.1.4. Single Cell Metabolomics
8.2.2. By Application
8.2.2.1. Oncology
8.2.2.2. Cell Biology
8.2.2.3. Neurology
8.2.2.4. Immunology
8.2.2.5. Others
8.2.3. By Country
8.2.3.1. India
8.2.3.2. Japan
8.2.3.3. Australia
8.2.3.4. Rest of Asia Pacific
8.2.4. Company Market Share (Top 3-5)
8.2.5. Economic Impact Study on Asia Pacific Single Cell Multi Omics Market
- South America Single Cell Multi Omics Market Overview
9.1. South America Single Cell Multi Omics Market Size & Forecast,2017-2030
9.1.1. Demand
9.1.1.1. By Value (USD Billion)
9.2. Market Share & Forecast, 2017-2030
9.2.1. By Product Type
9.2.1.1. Single Cell Genomics
9.2.1.2. Single Cell Proteomics
9.2.1.3. Single Cell Transcriptomics
9.2.1.4. Single Cell Metabolomics
9.2.2. By Application
9.2.2.1. Oncology
9.2.2.2. Cell Biology
9.2.2.3. Neurology
9.2.2.4. Immunology
9.2.2.5. Others
9.2.3. By Country
9.2.3.1. Brazil
9.2.3.2. Argentina
9.2.3.3. Rest of South America
9.2.4. Company Market Share (Top 3-5)
9.2.5. Economic Impact Study on South America Single Cell Multi Omics Market
- The Middle East & Africa Single Cell Multi Omics Market Overview
10.1. The Middle East & Africa Single Cell Multi Omics Market Size & Forecast,2017-2030
10.1.1. Demand
10.1.1.1. By Value (USD Billion)
10.2. Market Share & Forecast, 2017-2030
10.2.1. By Product Type
10.2.1.1. Single Cell Genomics
10.2.1.2. Single Cell Proteomics
10.2.1.3. Single Cell Transcriptomics
10.2.1.4. Single Cell Metabolomics
10.2.2. By Application
10.2.2.1. Oncology
10.2.2.2. Cell Biology
10.2.2.3. Neurology
10.2.2.4. Immunology
10.2.2.5. Others
10.2.3. By Country
10.2.3.1. Saudi Arabia
10.2.3.2. UAE
10.2.3.3. South Africa
10.2.3.4. Rest of the Middle East & Africa
10.2.4. Company Market Share (Top 3-5)
10.2.5. Economic Impact Study on Middle East & Africa Single Cell Multi Omics Market
- Competitor Analysis
11.1. Company Description
11.2. Financial Analysis
11.3. Key Products
11.4. Key Management Personnel
11.5. Contact Address
11.6. SWOT Analysis
11.7. Company Profile
11.7.1. 10x Genomics, Inc.
11.7.2. 1CellBio
11.7.3. MissionBio
11.7.4. NanoString Technologies, Inc.
11.7.5. Fluidigm Corporation
11.7.6. Fluxion Biosciences
11.7.7. Bio-Rad Laboratories, Inc.
11.7.8. Celsee, Inc.
11.7.9. BGI Genomics Co. Ltd. GE LifeSciences
11.7.10. Illumina, Inc.
11.7.11. Takara Bio
11.7.12. QIAGEN N.V.
11.7.13. Other Prominent Players
Frequently Asked Questions (FAQ):
Single-cell multi-omics technologies typically measure individual molecules from the same individual cell, enabling more in-depth biological insights by analyzing each molecular layer from individual cells.
The global single-cell multi-omics market is estimated to reach USD 15.35 billion by 2030, and. It was valued at USD 2.31 billion in 2022.
The growth rate of the Single-cell multi-omics market is 20.12%.
The Asia Pacific region will lead the single-cell multi-omics market due to increased cancer patients, rising drug discovery outsourcing, investment in R&D for diagnostic labs and technological advancements.
High-tech technological advancements, High-tech technology are the key factors to drive the Single-cell multi-omics market.
